In re Clozapine Antitrust Litigation, MDL No. 874 (N.D. Ill. 1991)

Plaintiff States sought monetary damages and injunctive relief against Sandoz Pharmaceuticals Corporation (Sandoz), alleging the company unlawfully required those who purchased its drug, Clozapine, to also purchase distribution and patient monitoring services from Sandoz.

Read More →

U.S. v. USA Waste Services, 1999 U.S. District Lexis 17577 (N.D. OH, 1999)

U.S. Department of Justice (DOJ) and Plaintiff States sought to enjoin the merger agreement between USA Waste Services, Inc. (USA Waste) and Waste Management, Inc. (WMI), arguing that such a merger would substantially lessen the competition in the waste disposal and commercial waste hauling business.

Read More →

In Re: Insurance Antitrust Litigation, 938 F.2d 919, 1991-1 Trade Cases (CCH) & 69,460

Plaintiff States sought damages and injunctive relief, alleging that Defendant reinsurers, brokers and trade organizations conspired to reduce the availability to public entities of commercial general liability insurance during the mid-1980s.

Read More →

In re Coordinated Pretrial Proceedings in Petroleum Products Antitrust Litigation, MDL-150; 1992-2 Trade Cas. (CCH) ¶ 69,925 (C.D. Cal. 1992)

In 1973, The States of Florida and Connecticut sued several named petroleum companies in each individual state’s federal court. The States alleged that the companies conspired to raise or stabilize prices for refined oil products and they continually engaged in the mutual exchange of pricing and price-related information. Further, the States alleged that the Defendants conspired to create an artificial scarcity of crude and refined oil and that the oil companies conspired not to compete in bidding on plaintiffs annual bulk sale petroleum supply contracts. California, Arizona, Washington and Oregon also sued

Read More →

New Jersey v. Exxon Corp. No. 1:99CV03183 (D.D.C. Nov. 30, 1999); Alaska v. Exxon Corp. No. A99-618-CV (D. Alaska, Nov. 30, 1999); Texas v. Exxon Corp. No. 3-99CV 2709-L (N.D. Texas, Dallas, Dec. 3, 1999); California v. Exxon

Plaintiff States sought to enjoin the merger between Exxon Corporation (Exxon) and Mobil Corporation (Mobil), alleging that the merger would violate Section 7 of the Clayton Act because the acquisition would substantially lessen competition and/or tend to lessen competition in relevant markets in each of the States.

Read More →

In re Compact Disc Minimum Advertised Price Antitrust Litigation MDL No. 1361 (D. Me. 2002) MDL-1391; No. 00-CIV-5853 (BSJ) (S.D.N.Y Aug. 8, 2000) (complaint)

Plaintiff States sought damages and injunctive relief, alleging that Defendant CD distributors unlawfully conspired to implement stringent minimum advertised price (MAP) policies in violation of antitrust laws.

Read More →

California v. BP Amoco/p.l.c., 3:00-cv-00420-SI (N.D. Cal, Apr. 13, 2000); In the Matter of the British Petroleum Company and Amoco Corp. File No. 981-0345 1998 WL 910216

Plaintiff States, jointly with the Federal Trade Commission, sought to enjoin the merger between British Petroleum Company (BP) and Amoco Corporation (Amoco). It was alleged that the proposed merger would effectively reduce competition or create a monopoly in the sale of gasoline.

Read More →

In re Disposable Contact Lens Antitrust Litigation, 2001-1 Trade Cas. (CCH) & 73,150

Plaintiff States sought damages and injunctive relief against the three major contact lens makers and the American Optometric Association. The States alleged that defendants conspired to cut mail order companies and pharmacies out of the market for replacement contact lenses.

Read More →

In re Cardizem CD Antitrust Litigation 99-MD-1278 (E.D. Mich. Jan. 29, 2003), 332 F.3d 896 (6th Cir. 2003)

Plaintiff States sought damages and injunctive relief, alleging that defendants entered into an unlawful agreement attempting to delay or prevent the marketing of less expensive generic alternatives to Cardizem CD, a brand name drug used to prevent heart attacks. The Plaintiff States settled for $80 million, the bulk of which was to be used to reimburse purchasers including consumers, insurance companies and other third-party payers for overcharges paid for Cardizem CD between 1998 and 2003.

Read More →

Maryland et al v. Mitsubishi Electronics America; 1992-1 Trade Cas. (CCH) ¶69,743 (D. Md. 1992)

Plaintiff States sought damages and injunctive relief, alleging that Mitsubishi Electronics America, Inc. (MELA) conspired with its dealers to set or maintain the resale price of its electronics equipment. In the settlement with Plaintiff States, MELA was enjoined from engaging in the alleged conduct and agreed to pay $6 million dollars for administrative costs and to reimburse qualified buyers.

Read More →